Literature DB >> 11368848

Interactions between Rho GTPases and Rho GDP dissociation inhibitor (Rho-GDI).

J Fauré1, M C Dagher.   

Abstract

The Rho-GDP dissociation inhibitor (Rho-GDI) was used as bait in a two-hybrid screen of a human leucocyte cDNA library. Most of the isolated cDNAs encoded GTPases of the Rho subfamily: RhoA, B, C, Rac1, 2, CDC42 and RhoG. The newly discovered RhoH interacted very poorly with Rho-GDI. Another protein partner shared a homology with RhoA that points to Asp67(RhoA)-Arg68(RhoA)-Leu69(RhoA) as critical for interaction with Rho-GDI. A second screen with RhoA as bait led to the isolation of GDI only. In order to investigate the relative role of protein-protein and protein-lipid interactions between Rho GTPases and Rho-GDI, CAAX box mutants of RhoA were produced. They were found to interact with Rho-GDI as efficiently as wild type RhoA, indicating that protein-protein interactions alone lead to strong binding of the two proteins. The C-terminal polybasic region of RhoA was also shown to be a site of protein-protein interaction with Rho-GDI.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368848     DOI: 10.1016/s0300-9084(01)01263-9

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  21 in total

1.  Concordance and interaction of guanine nucleotide dissociation inhibitor (RhoGDI) with RhoA in oogenesis and early development of the sea urchin.

Authors:  Vanesa Zazueta-Novoa; Guadalupe Martínez-Cadena; Gary M Wessel; Roberto Zazueta-Sandoval; Laura Castellano; Jesús García-Soto
Journal:  Dev Growth Differ       Date:  2011-04       Impact factor: 2.053

Review 2.  RHO GTPase signaling for axon extension: is prenylation important?

Authors:  Filsy Samuel; DiAnna L Hynds
Journal:  Mol Neurobiol       Date:  2010-09-28       Impact factor: 5.590

3.  Geranylgeranyltransferase type I (GGTase-I) deficiency hyperactivates macrophages and induces erosive arthritis in mice.

Authors:  Omar M Khan; Mohamed X Ibrahim; Ing-Marie Jonsson; Christin Karlsson; Meng Liu; Anna-Karin M Sjogren; Frida J Olofsson; Mikael Brisslert; Sofia Andersson; Claes Ohlsson; Lillemor Mattsson Hultén; Maria Bokarewa; Martin O Bergo
Journal:  J Clin Invest       Date:  2011-01-25       Impact factor: 14.808

4.  Regulation of protein transport from the Golgi complex to the endoplasmic reticulum by CDC42 and N-WASP.

Authors:  Ana Luna; Olga B Matas; José Angel Martínez-Menárguez; Eugenia Mato; Juan M Durán; José Ballesta; Michael Way; Gustavo Egea
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

Review 5.  RhoGDI: multiple functions in the regulation of Rho family GTPase activities.

Authors:  Athanassios Dovas; John R Couchman
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

6.  Rho/ROCK pathway and neural regeneration: a potential therapeutic target for central nervous system and optic nerve damage.

Authors:  Hai-Bo Tan; Yi-Sheng Zhong; Yu Cheng; Xi Shen
Journal:  Int J Ophthalmol       Date:  2011-12-18       Impact factor: 1.779

7.  SUMOylation of RhoGDIα is required for its repression of cyclin D1 expression and anchorage-independent growth of cancer cells.

Authors:  Zipeng Cao; Xueyong Li; Jingxia Li; Beipei Kang; Jingyuan Chen; Wenjing Luo; Chuanshu Huang
Journal:  Mol Oncol       Date:  2013-12-03       Impact factor: 6.603

8.  ZAK negatively regulates RhoGDIbeta-induced Rac1-mediated hypertrophic growth and cell migration.

Authors:  Chih-Yang Huang; Li-Chiu Yang; Kuan-Yu Liu; I-Chang Chang; Pao-Hsin Liao; Janet Ing-Yuh Chou; Ming-Yung Chou; Wei-Wen Lin; Jaw-Ji Yang
Journal:  J Biomed Sci       Date:  2009-06-18       Impact factor: 8.410

9.  Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway.

Authors:  Arye Elfenbein; John M Rhodes; Julia Meller; Martin A Schwartz; Michiyuki Matsuda; Michael Simons
Journal:  J Cell Biol       Date:  2009-07-06       Impact factor: 10.539

Review 10.  At the poles across kingdoms: phosphoinositides and polar tip growth.

Authors:  Till Ischebeck; Stephan Seiler; Ingo Heilmann
Journal:  Protoplasma       Date:  2009-12-20       Impact factor: 3.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.